JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lucchesi, B. R.
Right arrow Articles by Shivak, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lucchesi, B. R.
Right arrow Articles by Shivak, R.
Journal of Pharmacology And Experimental Therapeutics, Vol. 143, Issue 3, 366-373, 1964
Copyright © 1964 by American Society for Pharmacology and Experimental Therapeutics


EFFECT OF QUINIDINE AND PROCAINE AMIDE UPON ACETYLSTROPHANTHIDIN CARDIOTOXICITY

Benedict R. Lucchesi 1 and Robert Shivak 1

1 Department of Pharmacology, The University of Michigan, Ann Arbor, Michigan

Previous investigators, employing a variety of experimental procedures, have attempted to ascertain whether or not there exists an increased susceptibility to the cardiotoxic actions of the digitalis glycosides when used in conjunction with quinidine or procaine amide. The experimental results have not been in agreement. The possible reasons for these discrepancies have been discussed.

The present study has attempted to investigate this problem under carefully controlled conditions using the acetylstrophanthidin titration procedure previously described by Lown and Levine (1954). The previous administration of quinidine gluconate or procaine amide HCl to the experimental animal resulted in a significant increase in the dose of acetylstrophanthidin required to produce cardiotoxicity as evidenced by the onset of ventricular tachycardia, idioventricular rhythms and ventricular fibrillation. The doses of quinidine gluconate employed in this study have included those resulting in therapeutic plasma concentrations of the antiarrhythmic agent.

These data in the experimental animal demonstrate that the previous administration of nontoxic doses of quinidine do not have a synergistic action with the cardiotoxic effects of acetylstrophanthidin. The results obtained with procaine amide are in agreement with those obtained by previous investigators employing similar experimental techniques (Lown and Levine, 1954).

The clinical significance of these results is discussed. Caution is advised in attempting to apply results obtained under controlled experimental conditions to therapeutic situations in man.

Submitted on August 22, 1963
Accepted on November 13, 1963







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1964 by the American Society for Pharmacology and Experimental Therapeutics.